Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$0.2 - $0.5 $15,580 - $38,950
-77,900 Reduced 98.01%
1,584 $1,000
Q3 2021

Nov 02, 2021

SELL
$1.11 - $1.7 $67,283 - $103,047
-60,616 Reduced 43.27%
79,484 $98,000
Q2 2021

Aug 02, 2021

BUY
$1.46 - $2.25 $204,546 - $315,225
140,100 New
140,100 $237,000
Q2 2018

Aug 10, 2018

SELL
$1.44 - $2.24 $55,296 - $86,016
-38,400 Closed
0 $0
Q2 2017

Aug 11, 2017

BUY
N/A
38,400
38,400 $88,000

About TREVENA INC


  • Ticker TRVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 173,680,992
  • Market Cap $273M
  • Description
  • Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...
More about TRVN
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.